Artelis – « Brussels Innovation Award 2007 » is an international technology SME located at the Solvay Group R&T incubator in Brussels.
Artelis is concerned with process intensification needs in the biotech industry and provides innovative
solutions in the field of cell culture. Within the framework of process intensification, Artelis’ mission is to design, develop and manufacture the next generation means of production for protein, cell and virus. Artelis is developing : a compact and disposable high-cell density bioreactor. Artelis, which benefits from a US capital investment from a NASDAQ-listed company, is the privileged partner of world-leading pharmaceutical groups. Artelis, which is made up of 40 people, is a fast-growing company.
Company Details
- Employees
- 16
- Founded
- 2005
- Address
- Rue De Ransbeek 310, Brussels,1120,belgium
- Phone
- 352 27 60-1
- in****@****lis.net
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- artelis.be
- HQ
- Brussels
Artelis Questions
Artelis's helpline number is 352 27 60-1
Artelis's website is artelis.be
Artelis's LinkedIn profile is https://be.linkedin.com/company/artelis
Artelis has
16 employees.
View email and phone details for 16
employees at Artelis.
Artelis's industry is
Biotechnology Research
Artelis's top competitors are
Groupe Artelis,
Artelys,
Grupo Artemis,
Bip Partners,
Artelis Criações Com Papel,
Cyrespa Arquitectonico Sl,
Artelus.ai,
Artelia,
Artelispl,
Artelis S.a..
Artelis's support email address is info@artelis.net
Artelis's categories are Biotechnology Research
Artelis's founding year is 2005
